Browsing by Author Viney, R

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 19 of 19
Issue DateTitleAuthor(s)
Nov-2014COST-EFFECTIVENESS OF POST-THERAPY PET AND TELEPHONE INTERVIEW IN THE CLINICAL FOLLOW-UP OF PATIENTS TREATED WITH LOCALLY ADVANCED CERVICAL CANCER.Hou, C; Siva, S; Haas, M; Viney, R
6-Nov-2014Deriving a preference-based utility measure for cancer patients from the European Organisation for the Research and Treatment of Cancer's Quality of Life Questionnaire C30: a confirmatory versus exploratory approachCosta, D; Aaronson, N; Fayers, P; Grimison, P; Janda, M; Pallant, J; Rowen, D; Velikova, G; Viney, R; Young, T; King, M
Aug-2017Erratum to: Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format.Norman, R; Viney, R; Aaronson, NK; Brazier, JE; Cella, D; Costa, DSJ; Fayers, PM; Kemmler, G; Peacock, S; Pickard, AS; Rowen, D; Street, DJ; Velikova, G; Young, TA; King, MT
2016Evaluating the impact of hospital based drug and alcohol consultation liaison servicesReeve, R; Arora, S; Butler, K; Viney, R; Burns, L; Goodall, S; van Gool, K
2014Evaluation of NSW Health Drug and Alcohol Consultation Liaison Services. Report for the Mental Health Drug and Alcohol Office (MHDAO)Reeve, R; Arora, S; Viney, R; Goodall, S; van Gool, K; Knox, S; Kenny, PM
2017Health care use and costs at the end of life: A comparison of elderly Australian decedents with and without a cancer historyReeve, R; Srasuebkul, P; Langton, J; Haas, MR; Viney, R; Pearson, S-A
2016The hidden costs of drug and alcohol use in hospital emergency departmentsButler, K; Reeve, R; Arora, S; Viney, R; Goodall, S; van Gool, K; Burns, L
2018How should DCE with duration choice sets be presented for the valuation of health states?Mulhern, B; Norman, R; Shah, K; Bansback, N; Longworth, L; Viney, R
2016The impact of different DCE-based approaches when anchoring utility scoresNorman, R; Mulhern, BJ; Viney, R
2013The incidence and costs of chemotherapy side effectsPearce, AM; Haas, M; Viney, R
2017Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort studyPearce, AM; Haas, M; Viney, R; Pearson, S-A; Haywood, P; Brown, C; Ward, R
2017Is Dimension Order Important when Valuing Health States Using Discrete Choice Experiments Including Duration?Mulhern, B; Norman, R; Lorgelly, P; Lancsar, E; Ratcliffe, J; Brazier, J; Viney, R
2014The PACT Study Protocol: A time series study investigating the impact, acceptability and cost of an integrated model for psychosocial screening, care and treatment of patients with urological and head and neck cancersGirgis, A; Kelly, B; Boyes, A; Haas, M; Viney, R; Descallar, J; Candler, H; Bellamy, D; Prioetto, T
9-Jan-2014The PACT study protocol: a time series study investigating the impact, acceptability and cost of an integrated model for psychosocial screening, care and treatment of patients with urological and head and neck cancers.Girgis, A; Kelly, B; Boyes, A; Haas, M; Viney, R; Descallar, J; Candler, H; Bellamy, D; Proietto, A
2014Rates of chemotherapy adverse event in clinical practice: results from a prospective cohort studyPearce, AM; Haas, M; Viney, R; Pearson, S; Haywood, P; Ward, R
Dec-2015Resource use, costs and quality of end-of-life care: observations in a cohort of elderly Australian cancer decedents.Langton, JM; Srasuebkul, P; Reeve, R; Parkinson, B; Gu, Y; Buckley, NA; Haas, M; Viney, R; Pearson, SA; The End-of-Life in Cancer Care (EoL-CC) Investigators
2016Response patterns in health state valuation using endogenous attribute attendance and latent class analysisHole, AR; Norman, R; Viney, R
2018Tell me once, tell me soon: Parents’ preferences for clinical genetics services for congenital heart diseaseKasparian, N; De Abreu Lourenco, R; Winlaw, DS; Sholler, DF; Viney, R; Kirk, EPE
2017Valuing meta-health effects for use in economic evaluations to inform reimbursement decisions: a review of the evidenceDe Abreu Lourenco, R; Haas, M; Hall, J; Viney, R